High cocoa polyphenol rich chocolate may reduce the burden of the symptoms in chronic fatigue syndrome. Nutr J 9:55

Department of Endocrinology, Diabetes and Metabolism, Hull York Medical School, Michael White Diabetes Centre, Hull Royal Infirmary, 220-236 Anlaby Road, Hull, HU3 2RW UK.
Nutrition Journal (Impact Factor: 2.6). 11/2010; 9(1, article 55):55. DOI: 10.1186/1475-2891-9-55
Source: PubMed


Chocolate is rich in flavonoids that have been shown to be of benefit in disparate conditions including cardiovascular disease and cancer. The effect of polyphenol rich chocolate in subjects with chronic fatigue syndrome (CFS) has not been studied previously.
We conducted a double blinded, randomised, clinical pilot crossover study comparing high cocoa liquor/polyphenol rich chocolate (HCL/PR) in comparison to simulated iso-calorific chocolate (cocoa liquor free/low polyphenols(CLF/LP)) on fatigue and residual function in subjects with chronic fatigue syndrome. Subjects with CFS having severe fatigue of at least 10 out of 11 on the Chalder Fatigue Scale were enrolled. Subjects had either 8 weeks of intervention in the form of HCL/PR or CLF/LP, with a 2 week wash out period followed by 8 weeks of intervention with the other chocolate.
Ten subjects were enrolled in the study. The Chalder Fatigue Scale score improved significantly after 8 weeks of the HCL/PR chocolate arm [median (range) Exact Sig. (2-tailed)] [33 (25 - 38) vs. 21.5 (6 - 35) 0.01], but that deteriorated significantly when subjects were given simulated iso-calorific chocolate (CLF/CP) [ 28.5 (17 - 20) vs. 34.5 (13-26) 0.03]. The residual function, as assessed by the London Handicap scale, also improved significantly after the HCL/PR arm [0.49 (0.33 - 0.62) vs. 0.64 (0.44 - 0.83) 0.01] and deteriorated after iso-calorific chocolate [00.44 (0.43 - 0.68) vs. 0.36 (0.33 - 0.62)0.03]. Likewise the Hospital Anxiety and Depression score also improved after the HCL/PR arm, but deteriorated after CLF/CP. Mean weight remained unchanged throughout the trial.
This study suggests that HCL/PR chocolate may improve symptoms in subjects with chronic fatigue syndrome.

Download full-text


Available from: Duane Mellor
  • Source
    • "Reductions in mental fatigue were also accompanied by improvements in serial subtraction accuracy (Scholey et al., 2010). In a small pilot study, polyphenol-rich, relative to polyphenol-poor, chocolate reduced symptoms of anxiety and depression in 10 subjects with chronic fatigue (Sathyapalan et al., 2010). However, to our knowledge, the current randomized controlled trial is the first to report enhancement in positive mood states following cocoa polyphenol supplementation in a healthy non-clinical sample. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This study aimed to examine the acute and sub-chronic effects of cocoa polyphenols on cognition and mood. In a randomized, double-blind study, healthy middle-aged participants received a dark chocolate drink mix standardized to contain 500 mg, 250 mg or 0 mg of polyphenols (placebo) in a parallel-groups design. Participants consumed their assigned treatment once daily for 30 days. Cognition was measured with the Cognitive Drug Research system and self-rated mood with the Bond-Lader Visual Analogue Scale. Participants were tested at baseline, at 1, 2.5 and 4 h after a single acute dose and again after receiving 30 days of treatment. In total, 72 participants completed the trial. After 30 days, the high dose of treatment significantly increased self-rated calmness and contentedness relative to placebo. Mood was unchanged by treatment acutely while cognition was unaffected by treatment at all time points. This randomized controlled trial is perhaps the first to demonstrate the positive effects of cocoa polyphenols on mood in healthy participants. This provides a rationale for exploring whether cocoa polyphenols can ameliorate the symptoms associated with clinical anxiety or depression.
    Full-text · Article · Jan 2013 · Journal of Psychopharmacology
  • Source
    • "In addition, it has been verified that polyphenols can enhance learning and memory [42] [43] and reduce the risk of developing agerelated neurodegenerative diseases [44] [45], possibly via a decrease in reactive oxygen species (ROS) production and inflammation in models of aging [46] [47]. Besides antidepressant drugs, different polyphenolic compounds such as catechins (flavanols/flavonoid from green tea), curcumin (nonflavonoid from tumeric/Curcuma longa), and resveratrol (stilbenoid produced naturally by several plants when under attack/found high in red grape skin) have been observed to have antidepresssant-like effects in rodents and human [48] [49] [50] [51] [52]. This suggests that polyphenols could be key compounds for the improvement of psychiatric disorders like depression or anxiety. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Although it has been long believed that new neurons were only generated during development, there is now growing evidence indicating that at least two regions in the brain are capable of continuously generating functional neurons: the subventricular zone and the dentate gyrus of the hippocampus. Adult hippocampal neurogenesis (AHN) is a widely observed phenomenon verified in different adult mammalian species including humans. Factors such as environmental enrichment, voluntary exercise, and diet have been linked to increased levels of AHN. Conversely, aging, stress, anxiety and depression have been suggested to hinder it. However, the mechanisms underlying these effects are still unclear and yet to be determined. In this paper, we discuss some recent findings addressing the effects of different dietary polyphenols on hippocampal cell proliferation and differentiation, models of anxiety, and depression as well as some proposed molecular mechanisms underlying those effects with particular focus on those related to AHN. As a whole, dietary polyphenols seem to exert positive effects on anxiety and depression, possibly in part via regulation of AHN. Studies on the effects of dietary polyphenols on behaviour and AHN may play an important role in the approach to use diet as part of the therapeutic interventions for mental-health-related conditions.
    Full-text · Article · Jun 2012 · Oxidative Medicine and Cellular Longevity
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Chronic fatigue syndrome (CFS) is a poorly under-stood condition primarily characterized by debilitate-ing, persistent or recurrent fatigue, increased physi-cal and mental fatigability, cognitive impairment and widespread musculoskeletal pain. During the past two decades, there have been heated debates about CFS among researchers, practitioners and patients. The existence of the disorder has been questioned, its underlying pathophysiology debated and an effective treatment opposed (such as antidepressants, stimu-lants or antibiotics). A lot of multidisciplinary litera-ture is found about CFS, but to date, many psychia-trists seem to unknown the existence of this illness or think that it is a purely psychological disorder. How-ever, CFS is sitting on the border between medicine and psychiatry. The aim of this review is to make psychiatrists aware of the existence of CFS and that they will, one day, be confronted with the manage-ment of this illness. Thus, this update allows under-standing what is CFS, the diversity of physiopatho-logy underlined and its management.
    Full-text · Article ·
Show more